The event was attended by 500 students from Rayalaseema districts, Visakhapatnam, Guntur, Bapatla and the neighbouring states ...

Furthermore, Biocon has scheduled a board meeting on April 4 to discuss and approve fundraising for its commercial business ...

Biocon announced that its board is scheduled to meet on 4 April 2025 to consider raising funds through issuance of commercial papers (CP) or through any other mode via private placement basis.

Here's why one generic for Lipitor and other recognizable brands may have missed the mark compared to its recognizable ...

Analysts at Jefferies said that Indian pharmaceutical businesses, who depend heavily on the United States for their income, ...

Bengaluru: Syngene International, a listed subsidiary of Biocon Limited, has announced the appointment of Peter Bains as an ...

US President Trump announced a 27% tariff on India, affecting auto and IT sectors. Indian equity indices fell, but pharma ...

Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/04/2025 ,inter alia, to consider and approve Intimation of Board meeting for raising funds throu ...

Donald Trumps new 26% tariff on Indian imports has raised concerns about India's economic growth and export viability. While the pharmaceutical sector is temporarily exempt, brokerages warn of ...

If United States President Donald Trump's proposed 10 per cent flat tariff and country-specific tariffs -- including a 26 per ...

Syngene International appoints Peter Bains as MD & CFO. Syngene International announced that its board approved the ...

Sharing a video of the roads in San Cristobal Island, Ecuador, founder and CEO of Biocon, Kiran Mazumdar-Shaw criticised ...